« Previous
Next »
Leukemia Research
Volume 34, Issue 4
, Pages 475-482
, April 2010
ALK-negative anaplastic large cell lymphoma with extensive peripheral blood and bone marrow involvements manifested as “leukemic phase”
References
- The expression of the Hodgkin's disease-associated antigen Ki-1 in reactive and neoplastic lymphoid tissue: evidence that Reed–Sternberg cells and histiocytic malignancies are derived from activated lymphoid cells. Blood. 1985;66:848–858
- A translocation involving a specific breakpoint (q35) on chromosome 5 is characteristic of anaplastic large cell lymphoma (“Ki-1lymphoma”). Br J Haematol. 1989;71:31–36
- A novel translocation, t(2;5)(p23;q35), in childhood phagocytic large T-cell lymphoma mimicking malignant histiocytosis. Blood. 1989;73:806–813
- . Anaplastic large cell lymphoma, ALK-negative. In: Swerdlow S, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, et al. editor. World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues. Lyon: IARC Press; 2008;p. 317–319
- Fusion of a kinase gene, ALK, to a nucleolar protein gene, NPM, in non-Hodgkin's lymphoma. Science. 1994;263:1281–1284
- Detection of anaplastic lymphoma kinase (ALK) and nucleolar protein nucleophosmin (NPM)-ALK proteins in normal and neoplastic cells with the monoclonal antibody ALK1. Blood. 1997;89:1394–1404
- . Anaplastic large cell lymphoma: the shifting sands of diagnostic hematopathology. Mod Pathol. 2001;14:219–228
- Molecular detection of the (2;5) translocation of non-Hodgkin's lymphoma by reverse transcriptase-polymerase chain reaction. Blood. 1995;85:3416–3422
- Anaplastic large cell lymphomas expressing the novel chimeric protein p80NPM/ALK: a distinct clinicopathologic entity. Blood. 1995;86:1954–1960
- High incidence of the t(2;5)(p23;q35) translocation in anaplastic large cell lymphoma and its lack of detection in Hodgkin's disease: comparison of cytogenetic analysis, reverse transcriptase-polymerase chain reaction, and P-80 immunostaining. Blood. 1996;87:284–291
- Clinical features of 31 patients with Ki-1 anaplastic large-cell lymphoma. J Clin Oncol. 1991;9:539–547
- . A small-cell-predominant variant of primary Ki-1 (CD30)+ T-cell lymphoma. Am J Surg Pathol. 1993;17:859–868
- . Ki-1 anaplastic large cell lymphoma with a prominent leukemic phase. Hum Pathol. 1996;27:1093–1095
- Leukemia presentation of small cell variant anaplastic large cell lymphoma: report of four cases. Br J Haematol. 1999;104:680–688
- Anaplastic large-cell lymphoma with rapid evolution to leukemic phase. Ann Hematol. 1999;78:478–482
- Primary anaplastic large-cell lymphoma in adults: clinical presentation, immunophenotype, and outcome. Blood. 1997;90:3727–3734
- Anaplastic large cell Ki-1 lymphoma involving bone marrow: marrow findings and association with reactive hemophagocytosis. Am J Hematol. 1991;37:112–119
- Ki-1 (CD30)-positive large cell lymphoma present with leukemia: a case report. Fukuoka Igaku Zasshi. 1994;85:366–371
- CD30 and the NPM-ALK fusion protein (p80) are differentially expressed between peripheral blood and bone marrow in primary small cell variant of anaplastic large cell lymphoma. Am J Hematol. 2002;69:200–204
- ALK+ lymphoma: clinico-pathological findings and outcome. Blood. 1999;93:2697–2706
- Anaplastioc large cell lymphoma: a clinicopathologic study of 53 patients. Leuk Lymphoma. 1996;22:319–327
- Bone marrow involvement in anaplastic large cell lymphoma. Immunohistochemical detection of minimal disease and its prognostic significance. AM J Clin Pathol. 1995;103:82–89
- ALK-positive lymphoma: a single disease with a broad spectrum of morphology. Blood. 1998;91:2076–2084
- Coexpression of epithelial membrane antigen (EMA), Ki-1, and interleukin-2 receptor by anaplastic large cell lymphomas: diagnostic value in so-called malignant histiocytosis. Am J Pathol. 1988;130:59–70
- Anaplastic large-cell lymphomas of T-cell and null-cell phenotype express cytotoxic molecules. Blood. 1996;88:4005–4011
- Analysis of the t(2;5)(p23;q35) translocation by reverse transcription-polymerase chain reaction in CD30+ anaplastic large-cell lymphomas, in other non-Hodgkin's of T-cell phenotype, and in Hodgkin's disease. Blood. 1995;86:2321–2328
- ALK-anaplastic large-cell lymphoma is clinically and immunophenotypically different from both ALK+ ALCL and peripheral T-cell lymphoma, not otherwise specified: report from the International Peripheral T-Cell Lymphoma Project. Blood. 2008;111:5496–5504
- ALK-positive anaplastic large cell lymphoma with leukemic peripheral blood involvement is a clinicopathologic entity with an unfavorable prognosis: report of three cases and review of the literature. Am J Clin Pathol. 2003;120:617–625
- Pediatric ALK+ anaplastic large cell lymphoma with t(3;8)(q26.2;q24) translocation and c-myc rearrangement terminating in a leukemic phase. Am J Hematol. 2007;82:59–64
- Anaplastic large cell lymphoma in leukemic presentation: a case report and a review of the literature. J Pediatr Hematol Oncol. 2008;30(9):696–700
- . Highly aggressive ALK-positive anaplastic large cell lymphoma with a leukemic phase and multi-organ involvement: a report of three cases and a review of the literature. Ann Hematol. 2007;86:499–508
- . A leukemic change as an initial manifestation of the common variant type of ALK-positive anaplastic large cell lymphoma in a patient with lung adenocarcinoma. Intern Med. 2008;47:2057–2062
- Gene-expression profiling of systemic anaplastic large-cell lymphoma reveals difference based on ALK status and two distinct morphologic ALK+ subtypes. Blood. 2007;109:2156–2164
- A novel complex t(2;5;13)(p23;q35;q14) in small cell variant type anaplastic large cell lymphoma with peripheral involvement. Cancer Genet Cytogenet. 2004;154:183–185
- Unusual childhood extramedullary hematologic malignancy with natural killer cell properties that contains tropomyosin 4-anaplastic lymphoma kinase gene fusion. Blood. 2001;98:1209–1216
- . Anaplastic large-cell lymphoma presenting as acute leukemia. Am J Hematol. 2005;79:164–165
- . Anaplastic large cell lymphoma in leukemic phase: extraordinarily high white blood cell count. Pathol Int. 2009;59(May (5)):345–353
PII: S0145-2126(09)00383-X
doi: 10.1016/j.leukres.2009.07.034
© 2009 Elsevier Ltd. All rights reserved.
« Previous
Next »
Leukemia Research
Volume 34, Issue 4
, Pages 475-482
, April 2010
